Koers Protech Home Medical Corp Toronto S.E.
Aandelen
PHM
CA70324G1063
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 358 mln. 262 mln. 242 mln. | Omzet 2025 * | 388 mln. 283 mln. 262 mln. | Marktkapitalisatie | 184 mln. 134 mln. 124 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -2 mln. -1,46 mln. -1,35 mln. | Nettowinst (verlies) 2025 * | 3 mln. 2,19 mln. 2,02 mln. | EV/omzet 2024 * | 0,51 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,47 x |
K/w-verhouding 2024 * |
-51,2
x | K/w-verhouding 2025 * |
26,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,08% |
Recentste transcriptie over Protech Home Medical Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Crawford
CEO | Chief Executive Officer | - | 19-04-16 |
Hardik Mehta
DFI | Director of Finance/CFO | - | 15-02-18 |
Mark Miles
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Crawford
CEO | Chief Executive Officer | - | 19-04-16 |
Mark Greenberg
BRD | Director/Board Member | - | 21-12-17 |
Kevin Carter
BRD | Director/Board Member | - | 07-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,74% | 83,47 mld. | |
-29,66% | 69,72 mld. | |
0,00% | 26,5 mld. | |
+3,06% | 17,69 mld. | |
-12,16% | 16,83 mld. | |
+2,47% | 15,7 mld. | |
+74,82% | 13,45 mld. | |
+73,52% | 12,81 mld. | |
+0,76% | 12,69 mld. |